Article

The worldwide association of ultraviolet (UV)-B light and vitamin D status with T1D and multiple sclerosis is now more than evident.

In a recent plenary session entitled “Cell Therapy in Type 1 Diabetes” that closed the 2016 meeting of the European Society for Paediatric Endocrinology in Paris, Bart O. Roep announced the initiation of phase 1 clinical trials in humans in 2016 with the following protocol: dendritic cells will be isolated from the patient’s peripheral blood, cultured with calcitriol, and then re-injected in an abdominal intradermal position to ‘teach’ the rest of the immune cells not to attack β-cells anymore.

Read the full article

31.12.2017
 
Comments
Order by: 
Per page:
 
  • There are no comments yet
Actions
Rating
0 votes
Recommend